WNT5A inhibitors have been shown to effectively suppress melanoma cell invasion in vitro by blocking WNT5A signalling,50, 51 and have been identified as potential therapeutic options for ovarian cancer,52 however, validation of their clinical utility in vivo is urgently required. The gene discussed is WNT5A; the disease is melanoma.